ARCH Venture Partners is a venture capital firm that focuses on life science discoveries to prevent, detect, and cure disease. It invests in early-stage companies in the biotechnology and pharmaceutical sectors, particularly those involved in disruptive innovations aimed at improving healthcare outcomes.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions